|
[1]
|
Juliano, R.L. and Ling, V. (1976) A Surface Glycoprotein Modulating Drug Permeability in Chinese Hamster Ovary Cell Mutants. Biochimica et Biophysica Acta, 455, 152-162.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Dietrich, C.G., Geier, A. and Oude Elferink, R.P. (2003) ABC of Oral Bioavailability: Transporters as Gatekeepers in the Gut. Gut, 52, 1788-1795.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Balça-Silva, J., Matias, D., Carmo, A.D., et al. (2019) Cellular and Molecular Mechanisms of Glioblastoma Malignancy: Implications in Resistance and Therapeutic Strategies. Seminars in Cancer Biology, 58, 130-141.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Karthika, C., Sureshkumar, R., Zehravi, M., et al. (2022) Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein. Life (Basel), 12, Article No. 897.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
杨晓波, 刘克辛. P-糖蛋白分子结构及转运机制[J]. 药物评价研究, 2018, 41(1): 1-4.
|
|
[6]
|
张海威, 张力. 血脑脊液屏障上P-糖蛋白的研究进展[J]. 神经药理学报, 2016, 6(2): 53-64.
|
|
[7]
|
Klimecki, W.T., Futscher, B.W., Grogan, T.M., et al. (1994) P-Glycoprotein Expression and Function in Circulating Blood Cells from Normal Volunteers. Blood, 83, 2451-2458.
[Google Scholar] [CrossRef]
|
|
[8]
|
Kim, Y. and Chen, J. (2018) Molecular Structure of Human P-Glycoprotein in the ATP-Bound, Outward-Facing Conformation. Science, 359, 915-919.
[Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Robinson, K. and Tiriveedhi, V. (2020) Perplexing Role of P-Glycoprotein in Tumor Microenvironment. Frontiers in Oncology, 10, Article No. 265.
[Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
王慧. P-糖蛋白在神经细胞内的降解机制及其临床意义[D]: [硕士学位论文]. 泰安: 泰山医学院, 2014.
|
|
[11]
|
Begicevic, R.R. and Falasca, M. (2017) ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. International Journal of Molecular Sciences, 18, Article No. 2362.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Andersen, V., Vogel, U., Godiksen, S., et al. (2013) Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis. PLOS ONE, 8, e0072119.
[Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ahrweiler-Sawaryn, M.C., Biswas, A., Frias, C., et al. (2023) Novel Gold (I) Complexes Induce Apoptosis in Leukemia Cells via the ROS-Induced Mitochondrial Pathway with an Upregulation of Harakiri and Overcome Multi-Drug Resistances in Leukemia and Lymphoma Cells and Sensitize Drug Resistant Tumor Cells to Apoptosis in Vitro. Biomedicine & Pharmacotherapy, 161, Article ID: 114507.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Xavier, A.C., Suzuki, R. and Attarbaschi, A. (2023) Diagnosis and Management of Rare Paediatric Non-Hodgkin Lymphoma. Best Practice & Research Clinical Haematology, 12, Article ID: 101440.
[Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Henrique, R., Oliveira, A.I., Costa, V.L., Baptista, T., et al. (2013) Epigenetic Regulation of MDR1 Gene through Post-Translational Histone Modifications in Prostate Cancer. BMC Genomics, 14, Article No. 898.
[Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Demidenko, R., Razanauskas, D., Daniunaite, K., Lazutka, J.R., et al. (2015) Frequent Down-Regulation of ABC Transporter Genes in Prostate Cancer. BMC Cancer, 15, Article No. 683.
[Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chatterjee, S., Deshpande, A.A. and Shen, H. (2023) Recent Advances in the in Vitro and in Vivo Methods to Assess Impact of P-Glycoprotein and Breast Cancer Resistance Protein Transporters in Central Nervous System Drug Disposition. Biopharmaceutics & Drug Disposition, 44, 7-25.
[Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gan, H.K., Day, B.W., Harrup, R., et al. (2023) Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. Current Oncology Reports, 25, 589-598.
[Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Heming, C.P., Muriithi, W., Macharia, L.W., et al. (2022) P-Glycoprotein and Cancer: What Do We Currently Know? Heliyon, 8, e11171.
[Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Abd El-Fattah, E.E. (2023) Tumor Lysis Syndrome Promotes Cancer Chemoresistance and Relapse through AMPK Inhibition. International Immunopharmacology, 114, Article ID: 109568.
[Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Miletti-González, K.E., Chen, S., Muthukumaran, N., et al. (2005) The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer. Cancer Research, 65, 6660-6667.
[Google Scholar] [CrossRef]
|
|
[22]
|
Zhang, F., Zhang, L., Zhang, B., et al. (2009) Anxa2 Plays a Critical Role in Enhanced Invasiveness of the Multidrug Resistant Human Breast Cancer Cells. Journal of Proteome Research, 8, 5041-5047.
[Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhang, H.C., Zhang, F., Wu, B., et al. (2012) Identification of the Interaction between P-Glycoprotein and Anxa2 in Multidrug-Resistant Human Breast Cancer Cells. Cancer Biology & Medicine, 9, 99-104.
|
|
[24]
|
Lokman, N.A., Ween, M.P., Oehler, M.K., et al. (2011) The Role of Annexin A2 in Tumorigenesis and Cancer Progression. Tumor Microenvironment, 4, 199-208.
[Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wang, T., Wang, Z., Niu, R., et al. (2019) Crucial Role of Anxa2 in Cancer Progression: Highlights on Its Novel Regulatory Mechanism. Cancer Biology & Medicine, 16, 671-687.
[Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Zhang, F., Zhang, H., Wang, Z., et al. (2014) P-Glycoprotein Associates with Anxa2 and Promotes Invasion in Multidrug Resistant Breast Cancer Cells. Biochemical Pharmacology, 87, 292-302.
[Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Goebel, J., Chmielewski, J. and Hrycyna, C.A. (2021) The Roles of the Human ATP-Binding Cassette Transporters P-Glycoprotein and ABCG2 in Multidrug Resistance in Cancer and at Endogenous Sites: Future Opportunities for Structure-Based Drug Design of Inhibitors. Cancer Drug Resistance, 4, 784-804.
[Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
George, R., Hehlgans, S., Fleischmann, M., et al. (2022) Advances in Nanotechnology-Based Platforms for Survivin-Targeted Drug Discovery. Expert Opinion on Drug Discovery, 17, 733-754.
[Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Liu, F., Liu, S., He, S., et al. (2010) Survivin Transcription Is Associated with P-Glycoprotein/MDR1 Overexpression in the Multidrug Resistance of MCF-7 Breast Cancer Cells. Oncology Reports, 23, 1469-1475.
[Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Coley, H.M. (2010) Overcoming Multidrug Resistance in Cancer: Clinical Studies of p-Glycoprotein Inhibitors. Methods in Molecular Biology, 596, 341-358.
[Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ranasinghe, R., Mathai, M. and Zulli, A. (2022) Revisiting the Therapeutic Potential of Tocotrienol. BioFactors, 48, 813-856.
[Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Fang, Y., Ji, W. and Yan, C. (2022) Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma. Disease Markers, 2022, Article ID: 1195875.
[Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Katayama, K., Noguchi, K. and Sugimoto, Y. (2013) FBXO15 Regulates P-Glycoprotein/ABCB1 Expression through the Ubiquitin-Proteasome Pathway in Cancer Cells. Cancer Science, 104, 694-702.
[Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Huang, B., Fu, S.J., Fan, W.Z., et al. (2016) PKCε Inhibits Isolation and Stemness of Side Population Cells via the Suppression of ABCB1 Transporter and PI3K/Akt, MAPK/ERK Signaling in Renal Cell Carcinoma Cell Line 769P. Cancer Letters, 376, 148-154.
[Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Chen, Y., Zhang, K., Li, Y., et al. (2019) Oestrogen-Related Receptor Alpha Mediates Chemotherapy Resistance of Osteosarcoma Cells via Regulation of ABCB1. Journal of Cellular and Molecular Medicine, 23, 2115-2124.
[Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Zhao, X., Yang, L., Hu, J. and Ruan, J. (2010) miR-138 Might Reverse Multidrug Resistance of Leukemia Cells. Leukemia Research, 34, 1078-1082.
[Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Verscheijden, L.F.M., van Hattem, A.C., Pertijs, J.C.L.M., et al. (2020) Developmental Patterns in Human Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier ABC Drug Transporter Expression. Histochemistry and Cell Biology, 154, 265-273.
[Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
徐敏, 刘春风, 吴小伟, 等. 慢性癫痫SD大鼠模型海马P-糖蛋白表达的研究[J]. 苏州大学学报, 2007, 4(2): 193-195.
|
|
[39]
|
Lazarowski, A. and Czornyj, L. (2011) Potential Role of Multidrug Resistant Proteins in Refractory Epilepsy and Antiepileptic Drugs Interactions. Drug Metabolism and Drug Interactions, 26, 21-26.
[Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Wang, C., Hong, Z. and Chen, Y. (2015) Involvement of p38 MAPK in the Drug Resistance of Refractory Epilepsy through the Regulation Multidrug Resistance-Associated Protein 1. Neurochemical Research, 40, 1546-1553.
[Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
郑玲艳, 韩瑞兰, 曹俊彦. β-淀粉样蛋白在阿尔茨海默病中的作用[J]. 内蒙古医科大学学报, 2016, 38(2): 147-150.
|
|
[42]
|
郑伟. hSIR2/SIRT1降低蒽环类抗肿瘤药多柔比星的心脏毒性[D]: [博士学位论文]. 北京: 中国协和医科大学, 2009: 45-59.
|
|
[43]
|
杨兴艳, 薛月珍. 紫杉醇心脏毒性研究进展[J]. 医药导报, 2009, 28(8): 1064-1067.
|
|
[44]
|
Nath, A., Kumar Rai, M., Hashim, Z., et al. (2020) Prevalence of p-Glycoprotein (PGP) Expression, Function and Its Effect on Efficacy of Rifampicin in Patients with Lymph Node Tuberculosis. Indian Journal of Tuberculosis, 67, 172-176.
[Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Cort, A. and Ozben, T. (2015) Natural Product Modulators to Overcome Multidrug Resistance in Cancer. Nutrition and Cancer, 67, 411-423.
[Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Cabaud, O., Berger, L., Crompot, E., Adélaide, J., Finetti, P., Garnier, S., et al. (2022) Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate. Molecular Cancer Therapeutics, 21, 1227-1235.
[Google Scholar] [CrossRef]
|
|
[47]
|
Qin, S., Zhang, Z., Huang, Z., Luo, Y., Weng, N., Li, B., et al. (2023) CCT251545 Enhances Drug Delivery and Potentiates Chemotherapy in Multidrug-Resistant Cancers by Rac1-Mediated Macropinocytosis. Drug Resistance Updates, 66, Article ID: 100906.
[Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
雷思羽, 何屹. P-糖蛋白与膀胱肿瘤耐药关系的研究进展[J]. 江苏医药, 2019, 45(10): 1065-1068.
|
|
[49]
|
乔婉晴, 涂巍. 乳腺癌实施化疗后癌干细胞同P-糖蛋白及耐药蛋白在残存癌组织中表达的相关性[J]. 中国医学前沿杂志, 2014, 6(5): 123-125.
|
|
[50]
|
Dinić, J., Podolski-Renić, A., Jovanović, M., et al. (2019) Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. International Journal of Molecular Sciences, 20, Article No. 4575.
[Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wang, Y., Li, Y., Shang, D., et al. (2019) Interactions between Artemisinin Derivatives and P-Glycoprotein. Phytomedicine, 60, Article ID: 152998.
[Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Mellor, H.R. and Callaghan, R. (2011) Accumulation and Distribution of Doxorubicin in Tumour Spheroids: The Influence of Acidity and Expression of P-Glycoprotein. Cancer Chemotherapy & Pharmacology, 68, 1179-1190.
[Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Finch, A. and Pillans, P. (2014) P-Glycoprotein and Its Role in Drug-Drug Interactions. Australian Prescriber, 37, 137-139.
[Google Scholar] [CrossRef]
|
|
[54]
|
Harmsze, A.M., Robijns, K., van Werkum, J.W., et al. (2010) The Use of Amlodipine, but Not of P-Glycoprotein Inhibiting Calcium Channel Blockers Is Associated with Clopidogrel Poor-Response. Thrombosis and Haemostasis, 103, 920-925.
[Google Scholar] [CrossRef]
|
|
[55]
|
Pusztai, L., Wagner, P., Ibrahim, N., et al. (2005) Phase II Study of Tariquidar, a Selective P-Glycoprotein Inhibitor, in Patients with Chemotherapy-Resistant, Advanced Breast Carcinoma. Cancer, 104, 682-691.
[Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Tamaki, A., Ierano, C., Szakacs, G., et al. (2011) The Controversial Role of ABC Transporters in Clinical Oncology. Essays in Biochemistry, 50, 209-232.
[Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Cripe, L.D., Uno, H., Paietta, E.M., et al. (2010) Zosuquidar, a Novel Modulator of P-Glycoprotein, Does Not Improve the Outcome of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Randomized, Placebo-Controlled Trial of the Eastern Cooperative Oncology Group 3999. Blood, 116, 4077-4085.
[Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Halder, J., Pradhan, D., Kar, B., Ghosh, G., et al. (2022) Nanotherapeutics Approaches to Overcome P-Glycoprotein- Mediated Multi-Drug Resistance in Cancer. Nanomedicine, 40, Article ID: 102494.
[Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Labbozzetta, M., Poma, P. and Notarbartolo, M. (2023) Natural Inhibitors of P-Glycoprotein in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24, Article No. 4140.
[Google Scholar] [CrossRef] [PubMed]
|